Publications by authors named "Patrick A Calvert"

Background: Cerebral amyloid angiopathy (CAA) is a common cause of intracerebral haemorrhage (ICH) with a high recurrence risk. Left atrial appendage occlusion (LAAO) is a method for ischaemic stroke prevention in patients with atrial fibrillation (AF), potentially reducing the risk of intracranial bleeding in CAA-associated ICH. We aimed to determine the outcomes of patients with AF with CAA-associated ICH undergoing LAAO.

View Article and Find Full Text PDF

Background: Heart failure is common, complex, and often associated with coexisting chronic medical conditions and a high mortality. We aimed to assess the epidemiology of people admitted to hospital with heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), including the period covering the COVID-19 pandemic, which was previously not well characterised.

Methods: In this retrospective, cohort study, we used whole-population electronic health records with 57 million individuals in England to identify patients hospitalised with heart failure as the primary diagnosis in any consultant episode of an in-patient admission to a National Health Service (NHS) hospital.

View Article and Find Full Text PDF

Introduction: There are sex differences in the extent, severity, and outcomes of coronary artery disease. We aimed to assess the influence of sex on coronary atherosclerotic plaque activity measured using coronary F-sodium fluoride (F-NaF) positron emission tomography (PET), and to determine whether F-NaF PET has prognostic value in both women and men.

Methods: In a post-hoc analysis of observational cohort studies of patients with coronary atherosclerosis who had undergone F-NaF PET CT angiography, we compared the coronary microcalcification activity (CMA) in women and men.

View Article and Find Full Text PDF
Article Synopsis
  • Ventricular septal defects are a serious complication that can occur after a heart attack, and if untreated, they have a near 100% mortality rate.
  • Even surgical or other treatment options carry a high risk of mortality, and there are currently no randomized controlled trials to guide optimal treatment approaches.
  • This review aims to detail the diagnosis, effects on blood flow, and treatment options for these defects post-heart attack, highlighting existing research gaps and key questions that need addressing.
View Article and Find Full Text PDF

Background: Total coronary atherosclerotic plaque activity across the entire coronary arterial tree is associated with patient-level clinical outcomes.

Objectives: We aimed to investigate whether vessel-level coronary atherosclerotic plaque activity is associated with vessel-level myocardial infarction.

Methods: In this secondary analysis of an international multicenter study of patients with recent myocardial infarction and multivessel coronary artery disease, we assessed vessel-level coronary atherosclerotic plaque activity using coronary F-sodium fluoride positron emission tomography to identify vessel-level myocardial infarction.

View Article and Find Full Text PDF

Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been studied in large international randomised trials and registries and was approved by the National Institute for Health and Care Excellence in 2014 and by NHS England in 2018. This position statement summarises the evidence for left atrial appendage occlusion and presents the current indications.

View Article and Find Full Text PDF

Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been studied in large international randomised trials and registries and was approved by the National Institute for Health and Care Excellence in 2014 and by NHS England in 2018. This position statement summarises the evidence for left atrial appendage occlusion and presents the current indications.

View Article and Find Full Text PDF

Post-infarction ventricular septal defect is a mechanical complication of acute MI. The incidence of this complication is low in the primary percutaneous coronary intervention era. However, the associated mortality is very high at 94% with medical management alone.

View Article and Find Full Text PDF

Importance: Recurrent coronary events in patients with recent myocardial infarction remain a major clinical problem. Noninvasive measures of coronary atherosclerotic disease activity have the potential to identify individuals at greatest risk.

Objective: To assess whether coronary atherosclerotic plaque activity as assessed by noninvasive imaging is associated with recurrent coronary events in patients with myocardial infarction.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the safety and effectiveness of percutaneous closure for paravalvular leaks (PVL) after transcatheter aortic valve implantation (TAVI) across 14 hospitals from January 2018 to October 2022.
  • A total of 45 patients, primarily elderly males, experienced a high success rate (94%) in closing severe and moderate leaks, leading to significant clinical improvements post-procedure.
  • The findings suggest that percutaneous PVL closure is a safe and effective treatment, with positive long-term outcomes, including reduced heart failure hospitalizations and survival rates after intervention.
View Article and Find Full Text PDF

Background: Assessing inflammatory disease activity in large vessel vasculitis (LVV) can be challenging by conventional measures.

Objectives: We aimed to investigate somatostatin receptor 2 (SST) as a novel inflammation-specific molecular imaging target in LVV.

Methods: In a prospective, observational cohort study, in vivo arterial SST expression was assessed by positron emission tomography/magnetic resonance imaging (PET/MRI) using Ga-DOTATATE and F-FET-βAG-TOCA.

View Article and Find Full Text PDF

Prosthetic paravalvular leaks (PVLs) are associated with congestive heart failure and hemolysis. Surgical PVL closure carries high risks. Transcatheter implantation of occluding devices in PVL is a lower risk but challenging procedure.

View Article and Find Full Text PDF

Aims: Post-infarction ventricular septal defect (PIVSD) is a mechanical complication of acute myocardial infarction (AMI) with a poor prognosis. Surgical repair is the mainstay of treatment, although percutaneous closure is increasingly undertaken.

Methods And Resuts: Patients treated with surgical or percutaneous repair of PIVSD (2010-2021) were identified at 16 UK centres.

View Article and Find Full Text PDF

A 74-year-old man with no co-morbidities presented to hospital with a 3-day history of diarrhoea and vomiting. He met the modified Duke's criteria for definite infective endocarditis and was immediately started on an intravenous antibiotic. Over Days 1-9, he developed renal failure.

View Article and Find Full Text PDF

Paravalvular leak (PVL) is a challenging complication of valve replacement surgery that can cause heart failure and haemolysis. Surgical repair is the traditional treatment for severe, symptomatic PVL, but many patients with PVL fall into high-risk categories for redo surgery. Percutaneous techniques for closure of PVL have been increasingly refined over the last decade with availability of approved purpose-specific devices for closure.

View Article and Find Full Text PDF

Introduction: Observational studies have shown that migraine has been associated with patent foramen ovale (PFO). Whilst studies investigating PFO closure for the treatment of migraine have been neutral, there is some evidence that symptoms of migraine may improve if the PFO was closed after ischemic stroke.

Aim: To establish whether closure of PFO in patients with stroke or transient ischemic attack (TIA) is associated with reduction in the severity of co-existent migraine headaches.

View Article and Find Full Text PDF

Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people, it is a benign finding; however, in some people, the PFO can open widely to enable paradoxical embolus to transit from the venous to arterial circulation, which is associated with stroke and systemic embolisation. Percutaneous closure of the PFO in patients with cryptogenic stroke has been undertaken for a number of years, and a number of purpose-specific septal occluders have been marketed.

View Article and Find Full Text PDF
Article Synopsis
  • Postinfarct ventricular septal defects (VSDs) are rare but serious complications following a heart attack, with a very low survival rate without treatment, highlighting the urgency of intervention.
  • Recent advancements in transcatheter technology provide a less invasive closure option that has shown promising results comparable to traditional surgery, with evidence of lasting effectiveness and lower long-term mortality.
  • Comprehensive cardiac imaging techniques are essential for assessing the VSD and guiding treatment, and decisions regarding closure methods should be made by a collaborative team of heart specialists.
View Article and Find Full Text PDF

A patient with a history of coronary artery bypass graft presented with breathlessness and was found to have an 11 × 6 cm aneurysm in a distally occluded saphenous vein graft. This case describes the investigation, heart team discussion, and percutaneous closure of the aneurysm. ().

View Article and Find Full Text PDF
Article Synopsis
  • Coronary perforation during acute coronary syndrome percutaneous coronary interventions (ACS-PCI) is rare, occurring in 0.37% of procedures, with consistent annual rates between 2007 and 2014.
  • Key predictors of coronary perforation include older age, female gender, chronic total occlusion interventions, and the use of multiple stents or rotational atherectomy, while different P2Y12 inhibitors did not show a significant effect.
  • The occurrence of coronary perforation is linked to worse clinical outcomes, and the use of glycoprotein inhibitors (GPI) is associated with increased rates of tamponade, highlighting the need for careful consideration of these factors in ACS-PCI procedures.
View Article and Find Full Text PDF

The role of glycoprotein IIb/IIIa inhibitors (GPI) in primary percutaneous coronary intervention (PPCI) remains uncertain. Previous analyses compare PPCI outcomes with clopidogrel plus GPI, versus without GPI. This does not reflect modern contemporary PPCI practice with ticagrelor or prasugrel.

View Article and Find Full Text PDF